Alnylam Pharmaceuticals Inc.
ALNY | NASDAQ
$244.32
+$4.76 (+1.99%)
At close: Sep 21, 2026, 4:00 PM ET
$244.35
+$0.03 (+0.01%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Net Income | 313.75M | -278.16M | -440.24M | -1.13B | -852.82M | -858.28M |
Depreciation & Amortization | 55.66M | 56.67M | 97.03M | 85.55M | 89.69M | 74.44M |
Stock-Based Compensation | 348.24M | 272.08M | 221.68M | 230.65M | 165.72M | 139.87M |
Other Working Capital | -168.36M | -232.22M | -509K | -147.59M | -122.85M | -38.42M |
Other Non-Cash Items | 253.42M | 261.94M | 214.93M | 309.24M | 174.24M | 95.76M |
Deferred Income Tax | -2.2M | -106.76M | n/a | n/a | -55.7M | -54.04M |
Change in Working Capital | -444.78M | -214.08M | 10.76M | -35.55M | -162.82M | -12.7M |
Operating Cash Flow | 524.08M | -8.31M | 104.16M | -541.27M | -641.69M | -614.96M |
Capital Expenditures | -58.7M | -34.28M | -62.21M | -72.06M | -76.37M | -70.36M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -1.36B | -1.71B | -1.82B | -1.98B | -1.66B | -2.03B |
Sales Maturities Of Investments | 1.8B | 1.57B | 1.55B | 2.23B | 1.46B | 1.69B |
Other Investing Acitivies | 57.63M | 57.76M | -4.44M | -13.19M | -4.36M | -31.2M |
Investing Cash Flow | 436.33M | -116.84M | -336.35M | 169.35M | -273.3M | -435.52M |
Debt Repayment | -546.95M | n/a | n/a | 254M | 500M | 200M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -8.27M | -8.79M | 24.67M | -87.61M | 500.85M | 695.48M |
Financial Cash Flow | -305.19M | 294.16M | 172.13M | 425.75M | 1.25B | 994.98M |
Net Cash Flow | 690.16M | 153.77M | -53.67M | 46.4M | 323.11M | -50.58M |
Free Cash Flow | 465.38M | -42.59M | 41.95M | -613.33M | -718.07M | -685.32M |
Adj. Free Cash Flow | 117.15M | -314.67M | -179.74M | -843.98M | -883.78M | -825.2M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | -58.7M | -34.28M | -62.21M | -72.06M | -76.37M | -70.36M |
Owner Earnings | 524.08M | -8.31M | 104.16M | -541.27M | -641.69M | -614.96M |
Add to Watchlist
Select watchlists to add or remove ALNY